Study S001391

A Novel Precision Medicine Approach For Obesity: A Randomized, Multi-Center Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Informed Consent Form (PDF)

Registration

Registration: NCT06814938
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: TRIPLE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 135
Start: 2025-02-21
Primary completion: 2027-12
Lead sponsor: Mayo Clinic
Conditions: Obesity
Interventions: DRUG:Semaglutide; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: NIH:1R44DK138619

Registered primary outcomes

Change in Total Body Weight at 24 weeks [Baseline, 24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.